Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New anticancer agents claimed by several research groups

Aug. 22, 2007

EMEA reviews new indication for Bioenvision's Evoltra

Aug. 21, 2007

FDA grants fast track designation to Adventrx's CoFactor

Aug. 21, 2007

Myriad begins third phase II trial of Azixa for lung cancer spread to the brain

Aug. 21, 2007

Recent patents cover HDAC inhibitors primarily for cancer

Aug. 21, 2007

The MMRC and Proteolix start carfilzomib phase II clinical trial in multiple myeloma

Aug. 20, 2007

EMEA recommends orphan drug status for Progen's PI-88 as it enters phase III trial

Aug. 20, 2007

Vion enrolls 85 elderly patients in pivotal phase II trial of Cloretazine for AML

Aug. 20, 2007

GSK begins phase I trial of GSK-923295 for solid tumors

Aug. 20, 2007

Millennium begins phase II trial of Velcade for MM

Aug. 20, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...